BHST · Bioharvest Sciences Inc. · Investor Relations

Vancouver, British Columbia and Rehovot, Israel-(Newsfile Corp. - March 17, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its proprietary Botanical Synthesis™ platform, today announced that it will report its fourth quarter and full year 2025 financial results after market close on Tuesday, March 31, 2026. The Company will host a conference call and webcast at 4:30 p.m. Eastern Daylight Time to discuss the results and provide an update on business operations. Fourth Quarter and Full Year 2025 Earnings Call Date: Tuesday, March 31, 2026 Time: 4:30 PM Eastern Time Webcast link: https://events.q4inc.com/attendee/512060117 The Earnings call webcast will be broadcast live, and attendees are encouraged to register via the webcast link at least 10 minutes prior to the call to ensure timely participation. The webcast recording will be available for replay on the Company's website within the Investor

Vancouver, British Columbia and Rehovot, Israel-(Newsfile Corp. - March 13, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that its Board of Directors has approved the grant of long-term incentive ("LTI") awards to employees, officers and directors under the Company's equity incentive plan. These grants are designed to align the interests of the Company's team with those of shareholders while supporting BioHarvest's continued growth and innovation across its core business segments. The awards consist of a combination of stock options and restricted share units ("RSUs") totaling 516,812 stock options and 264,121 RSUs. All stock options will be valid for 10 years as of today, and both stock options and RSUs will be priced at today's closing share value and will vest quarterly for a three-year period starting March 13, 2026. "Equity-based incentives play a central